DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Tack CJ, Jacob S, Desouza C. et al.
Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial.
Diabetes Obes Metab 2019;
21 (11) 2450-2459
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.